Dr. Charis Eng is Chair and Founding Director of the Genomic Medicine Institute at the Cleveland Clinic Foundation, and Professor and Vice Chairman, Department of Genetics, Case Western Reserve University School of Medicine.
Dr. Eng’s research interests may be broadly characterized as clinical cancer genetics translational research. Her work on RET testing in multiple endocrine neoplasia type 2 and the characterization of the widening clinical spectra of PTEN gene mutations have been acknowledged as the paradigm for the practice of clinical cancer genetics.
Dr. Eng has published over 230 peer-reviewed original papers in such journals as the New England Journal of Medicine, JAMA, Lancet, Nature Genetics, Nature.
In our wide-ranging SCIENCE AND SOCIETY interview, done on 8-9-07, Dr. Eng discusses
- What is genomic medicine?
- Personalized genetic risk assessment
- Genetic counseling
- Genetic testing and genetic screening